NICE approves AstraZeneca’s COPD drug
The National Institute for Health and Care Excellence (NICE) has published draft guidance recommending roflumilast (Daxas, AstraZeneca) for chronic obstructive pulmonary disease (COPD).
List view / Grid view
News
Steven Baertschi joins EPR advisory board
Dr Steven Baertschi has joined the editorial advisory board of European Pharmaceutical Review.
Fujifilm Diosynth Biotechnologies announce successful completion of its 100th paveway
Fujifilm Diosynth Biotechnologies has announced the successful completion of its 100th program using its pAVEway™ Advanced Protein Expression system...
62% of medicines dispensed in Europe are generic, says new IMS data
New IMS data reveals the growing importance of generic medicines for public health as they now account for 62% of medicines dispensed in Europe delivering huge value while impacting only 4% of total healthcare budgets.
Metrohm & CAMO Software are announcing a global partnership
Optimising analysis in the laboratory with modern instruments and high-performance software...
Sandoz receives EU approval for Erelzi (biosimilar etanercept)
The European Commission (EC) has approved Sandoz’ (a Novartis division) Erelzi (biosimilar etanercept) for use in Europe, to treat inflammatory diseases...
DiaSorin and Tecan to collaborate in new platform development
DiaSorin and Tecan Group have announced that they have agreed to collaborate in a development under which DiaSorin will make use of Tecan’s Fluent® Laboratory Automation Solution as its nucleic acid extraction platform...
CAMO releases new approach to modeling and monitoring time-dependent processes: Batch Modeling for the Unscrambler® X software suite
CAMO Software announced the release of Batch Modeling, a new add-on to their all-in-one Multivariate Data Analysis (MVA) and process monitoring software suite Unscrambler® X...
EU approval for Regeneron and Sanofi’s rheumatoid arthritis drug
The European Commission (EC) has granted marketing authorisation for Regeneron and Sanofi’s Kevzara (sarilumab) for the treatment of rheumatoid arthritis...
Cannabinoids suitable for migraine prevention
A study has confirmed that cannabinoids are just as suitable as a prophylaxis for migraine attacks as other pharmaceutical treatments.
PDA issues essential new guidance for visual inspections
A new technical report has clarified best practice on visual inspection for visible particles in parenterals.
Rise in product recalls prompts FDA to warn of possible BCC contamination
The US Food and Drug Administration (FDA) has advised manufacturers of non-sterile, water-based drug products that there have been recent product recalls due to Burkholderia cepacia complex (BCC) contamination.
Microneedle patches for flu vaccination prove successful in first human clinical trial
Small skin patches with dissolvable microneedles were safe and well-tolerated, generated robust immunity against influenza, could be self-administered by study participants and were strongly preferred over shots.
Amber warning for the UK’s access to new medicines post Brexit
Independent health economist lays out solution for how the UK could handle pharmaceutical regulation after Brexit.
DHL opens new state-of-the-art Life Sciences facility at Dublin Airport
Global logistics provider DHL Supply Chain is today opening a new pharmaceutical grade facility in Ireland.
